Anti-CD74 antibody [PIN.1]
2
(1 Review)
|
(12 Publications)
Mouse Monoclonal CD74 antibody. Suitable for IHC-P, ICC/IF, WB and reacts with Human samples. Cited in 12 publications. Immunogen corresponding to Synthetic Peptide within Human CD74 aa 1-50 conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
CD74, DHLAG, HLA class II histocompatibility antigen gamma chain, HLA-DR antigens-associated invariant chain, Ia antigen-associated invariant chain, Ii
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD74 antibody [PIN.1] (AB22603)
ab22603 staining CD74 in human liver. Staining is localized to the membrane and cytoplasm.
Left panel : with primary antibody at 4ug/ml. Right panel : isotype control.
Sections were stained using an automated system (Dako Autostainer plus), at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 antigen retrieval buffer, EDTA pH 9.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be req
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CD74 antibody [PIN.1] (AB22603)
ICC/IF image of ab22603 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab22603, 10μg/ml) overnight at +4°C. The secondary antibody (green) was ab96879, DyLight® 488 goat anti-mouse IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-CD74 antibody [PIN.1] (AB22603)
ICC/IF image of ab22603 staining CD74 in HaCaT cells. Cells were fixed with cold 100% methanol for 10 minutes at -20°C. Samples were incubated with primary antibody at 1 : 100 dilution for 1 hour at room temperature. A FITC Goat anti-mouse (green) was used as a secondary antibody at 1 : 50 dilution for 1 hour at room temperature.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CD74 antibody [PIN.1] (AB22603)
Immunofluorescent analysis of 2% Formaldehyde-fixed Cervical cancer cell line (HeLa) labeling CD74 with ab22603 at 1/100 dilution. Secondary antibody : FITC Goat Anti-Mouse (green) at 1/200 dilution. (A) DAPI (blue) nuclear stain. (B) Anti-CD74 Antibody. (C) Composite. (A) DAPI (blue) nuclear stain. (B) Anti-CD74 Antibody. (C) Composite.
- WB
Lab
Western blot - Anti-CD74 antibody [PIN.1] (AB22603)
Lanes 1 - 4 : Merged signal (red and green). Green - ab22603 observed at 35 kDa. Red - loading control, ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) observed at 55 kDa.
ab22603 was shown to react with CD74 in western blot. The band observed in CD74 knockout cell line ab273378 (knockout lysate ab275529) below 35 kDa is likely to represent a truncated form. This has not been investigated further. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab22603 and ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) overnight at 4 °C at 1 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-CD74 antibody [PIN.1] (ab22603) at 1 µg/mL
Lane 1:
Wild-type Raji cell lysate at 30 µg
Lane 2:
Western blot - Human CD74 knockout Raji cell lysate (<a href='/en-us/products/cell-lysates/human-cd74-knockout-raji-cell-lysate-ab275529'>ab275529</a>)
Lane 2:
CD74 knockout Raji cell lysate at 30 µg
Lane 2:
Western blot - Human CD74 knockout Raji cell line (<a href='/en-us/products/cell-lines/human-cd74-knockout-raji-cell-line-ab273378'>ab273378</a>)
Lane 3:
Jurkat cell lysate at 30 µg
Lane 4:
HepG2 cell lysate at 30 µg
Predicted band size: 34 kDa
Observed band size: 35 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD74 facilitates multiple immune regulatory processes. It forms a complex with the MHC II molecules aiding in their proper folding and peptide loading in the endoplasmic reticulum. This complex then travels through the Golgi apparatus towards the lysosomal compartments where antigens are presented to initiate adaptive immune responses. In addition CD74 is involved in signal transduction pathways that regulate cell proliferation and survival influenced by interactions with MIF and other molecules.
Pathways
The role of CD74 extends into both the antigen presentation and MIF signaling pathways. Within the antigen presentation pathway CD74's activity is tightly connected with MHC II and subsequently to CD4+ T cells facilitating the activation of these immune cells. The MIF signaling pathway involves CD74 interacting with CD44 a receptor that further propagates the signaling cascades essential for immune modulation and cell survival.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Cell reports 42:112525 PubMed37243592
2023
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 23:e55470 PubMed36215666
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:6322 PubMed33303760
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular & cellular proteomics : MCP 19:1619-1631 PubMed32641473
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature immunology 19:973-985 PubMed30127434
2018
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 8:806 PubMed28769925
2017
Applications
WB
Species
Human
Scientific reports 7:2775 PubMed28584258
2017
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 8: PubMed27854284
2016
Applications
Unspecified application
Species
Human
Journal of immunology (Baltimore, Md. : 1950) 195:3725-36 PubMed26371256
2015
Applications
Unspecified application
Species
Unspecified reactive species
Cancer discovery 4:415-22 PubMed24469108
2014
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com